Cases & Deals

  • Home
  • Practices
  • Merz Pharmaceuticals establishes joint venture in Brazil

Share

Merz Pharmaceuticals establishes joint venture in Brazil

February 2010

Client(s) Merz GmbH & Co. KGaA

Jones Day advised Merz Pharmaceuticals GmbH, a wholly owned subsidiary of Jones Day's long standing client Merz GmbH & Co. KGaA, on the establishment of a joint venture in Brazil. Merz' joint venture partner is Biolab Farmacêutica, one of Brazil's leading pharmaceutical companies. Biolab has been marketing some of Merz' products for quite some time in Brazil. The joint venture now agreed, in which Merz will have a 61% stake, will give Merz direct access to Brazil's growing market for pharmaceutical and aesthetical products.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.